Chris Viehbacher

Learn more about corporations VOTING to rewrite our laws.

Chris Viehbacher is the CEO of Sanofi-aventis and the Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA).

Ties to the American Legislative Exchange Council

PhRMA is a member of the Corporate ("Private Enterprise") Board of the American Legislative Exchange Council (ALEC), as of July 2011.

About ALEC

ALEC is a corporate bill mill. It is not just a lobby or a front group; it is much more powerful than that. Through ALEC, corporations hand state legislators their wishlists to benefit their bottom line. Corporations fund almost all of ALEC's operations. They pay for a seat on ALEC task forces where corporate lobbyists and special interest reps vote with elected officials to approve “model” bills. Learn more at the Center for Media and Democracy's ALECexposed.org, and check out breaking news on our PRWatch.org site.

Background

Viehbacher made €3.5 million in 2010. PhRMA is one of the largest and most influential lobbying organizations in Washington. Representing 48 pharmaceutical companies, PhRMA has 20 registered lobbyists on staff and has contracted with dozens of lobby and PR firms.

External resources

This article is a stub. You can help by expanding it.